DOI: https://doi.org/10.55522/jmpas.V4I5.0071.
VOLUM-4, ISSUE-5
Akshay Rajgaria*, Prajna Tripathy
Kanak Manjari Institute of Pharmaceutical Sciences (KMIPS), Rourkela, Odisha, India
Refer this article
Akshay Rajgaria, Prajna Tripathy, 2015. A short review on mitral valve prolapse. Journal of medical pharmaceutical and allied sciences, V 4 - I 5, Pages -271 – 273. Doi: https://doi.org/10.55522/jmpas.V4I5.0071.
ABSTRACT
Severe mitral regurgitation requiring surgery is the most common life-threatening complication of mitral valve prolapse (MVP) and is due to progressive myxomatous change in the valve. The overall prognosis of patients with mitral valve prolapse is excellent, but a small subset will develop serious complications, including infective endocarditis, sudden cardiac death, and severe mitral regurgitation. Mitral Valve Prolapse (MVP) is the most frequently diagnosed cardiac valvular abnormality. It is a primary disorder with familial occurrence. MVP is a disease of the young with a significantly higher incidence in women compared to men. The most characteristic clinical finding is a midsystolic click and late systolic murmur detected on cardiac auscultation.
Keywords:
Gaur gum, Chitosan, Nanoparticle, Scanning electron microscopy (SEM), FT-IR, AFM.